{"DataElement":{"publicId":"5918316","version":"1","preferredName":"Plerixafor Administered Reason","preferredDefinition":"An explanation that describes why plerixafor was administered.","longName":"3837076v1.0:5918314v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3837076","version":"1","preferredName":"Plerixafor Administered","preferredDefinition":"A bicyclam with hematopoietic stem cell-mobilizing activity. Plerixafor blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation._The act of having given something (e.g., a medication or test).","longName":"3837074v1.0:2233610v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3837074","version":"1","preferredName":"Plerixafor","preferredDefinition":"A bicyclam with hematopoietic stem cell-mobilizing activity. Plerixafor blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation.","longName":"C1777","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plerixafor","conceptCode":"C1777","definition":"A bicyclam with hematopoietic stem cell-mobilizing activity. Plerixafor blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2F6D39D-A121-A693-E040-BB89AD4336F3","latestVersionIndicator":"Yes","beginDate":"2013-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-02","modifiedBy":"ONEDATA","dateModified":"2013-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2F6D39D-A12F-A693-E040-BB89AD4336F3","latestVersionIndicator":"Yes","beginDate":"2013-08-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-08-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5918314","version":"1","preferredName":"Plerixafor Administered Reason","preferredDefinition":"A bicyclam with hematopoietic stem cell-mobilizing activity. Plerixafor blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation._The act of having given something (e.g., a medication or test)._An explanation of the cause of some phenomenon or action.","longName":"5918314v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Recipient at risk of mobilization failure","valueDescription":"Hematopoietic Stem Cell Mobilization Failure Risk","ValueMeaning":{"publicId":"5916024","version":"1","preferredName":"Hematopoietic Stem Cell Mobilization Failure Risk","longName":"5916024","preferredDefinition":"The recruitment of hematopoietic stem cells from the bone marrow into peripheral blood.: A lack of occurrence or performance.: The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell Mobilization","conceptCode":"C63494","definition":"The recruitment of hematopoietic stem cells from the bone marrow into peripheral blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"554F9EA8-12E5-4B79-E053-F662850AD678","latestVersionIndicator":"Yes","beginDate":"2017-07-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-07-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5628DCC7-27B3-7A6D-E053-F662850AB699","beginDate":"2017-08-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-08-07","modifiedBy":"ONEDATA","dateModified":"2017-08-07","deletedIndicator":"No"},{"value":"Planned per protocol","valueDescription":"Plan Protocol","ValueMeaning":{"publicId":"5918315","version":"1","preferredName":"Plan Protocol","longName":"5918315","preferredDefinition":"To devise, contrive, or form in design.: A rule which guides how an activity should be performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plan","conceptCode":"C25619","definition":"To devise, contrive, or form in design.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Protocol","conceptCode":"C42651","definition":"A rule which guides how an activity should be performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5628DCC7-27C0-7A6D-E053-F662850AB699","latestVersionIndicator":"Yes","beginDate":"2017-08-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-08-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5628DCC7-27D9-7A6D-E053-F662850AB699","beginDate":"2017-08-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-08-07","modifiedBy":"ONEDATA","dateModified":"2017-08-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008563","version":"1","preferredName":"Therapy Results","preferredDefinition":"the results or effects (does not include CTC Adverse Events) of therapeutic agents or procedures administered to the patient.","longName":"TX_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6690D31-4081-494A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-06","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-02-11","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5918313","version":"1","preferredName":"Plerixafor Administered Reason","preferredDefinition":"A bicyclam with hematopoietic stem cell-mobilizing activity. Plerixafor blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation.:The act of having given something (e.g., a medication or test).:An explanation of the cause of some phenomenon or action.","longName":"C1777:C25382:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plerixafor","conceptCode":"C1777","definition":"A bicyclam with hematopoietic stem cell-mobilizing activity. Plerixafor blocks the binding of stromal cell-derived factor (SDF-1alpha) to the cellular receptor CXCR4, resulting in hematopoietic stem cell (HSC) release from bone marrow and HSC movement into the peripheral circulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5628DCC7-2782-7A6D-E053-F662850AB699","latestVersionIndicator":"Yes","beginDate":"2017-08-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-08-07","modifiedBy":"ONEDATA","dateModified":"2017-08-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5628DCC7-2793-7A6D-E053-F662850AB699","latestVersionIndicator":"Yes","beginDate":"2017-08-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-08-07","modifiedBy":"NYCHM","dateModified":"2017-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"SNFM_MA_plerixafor_admin_rsn","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Why was plerixafor administer","type":"Preferred Question Text","description":"Why was plerixafor administered?","url":null,"context":"NHLBI"},{"name":"Indicate the reason for which plerixafor was given","type":"Alternate Question Text","description":"Indicate the reason for which plerixafor was given","url":null,"context":"NHLBI"},{"name":"Indicate the reason for which plerixafor was given","type":"Application Standard Question Text","description":"Indicate the reason for which plerixafor was given","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5628DCC7-27E6-7A6D-E053-F662850AB699","latestVersionIndicator":"Yes","beginDate":"2017-08-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-08-07","modifiedBy":"NYCHM","dateModified":"2017-09-29","changeDescription":"System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}